RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Lifeforce Capital
L

Lifeforce Capital portfolio

Lifeforce Capital has 5 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Venture capital.
Portfolio on Recent Funding: 5.
Deals, last 12 months: 1.
Rounds led: 1 of 4.
Capital in their rounds: $335.5M.
Latest deal: Aspen Neuroscience · Nov 20, 2025.
About this page

It is a venture capital firm based in Chevy Chase, US, founded in 2015. It led 1 of the 4 rounds it joined. Its most recent investment on record is Aspen Neuroscience's $115M Series B+ round in November 2025, alongside LYFE Capital, Kite Pharma, OrbiMed and 6 others. By category, its portfolio leans toward Health and bio (5) and Education (2). It has co-invested with S32, OrbiMed and LYFE Capital, most often S32 (3 rounds).

About Lifeforce Capital

Firm type: Venture capital.
Headquarters: Chevy Chase, US.
Founded: 2015.
Stages: Seed, Series A, Series B, Series C.
Sectors: Biotech, Digital Health, Healthtech, Medical Devices, SaaS.
Check size: $500K to $5M.
Leads rounds: No.
Portfolio companies: 64.
Exits: 7.
Rounds led: 3.

What Lifeforce Capital invests in

Lifeforce Capital recent investments

CompanyRoundDateAlongside
AAspen NeuroscienceSeries B+ · $115MLYFE Capital, Kite Pharma, OrbiMed (lead) +6
AAspen NeuroscienceSeries B+ · $147.5MLYFE Capital (lead), Newton Investment Management, Mirae Asset Capital +6
CCharacter BioSeries A · $18MCasdin Capital, Cantos, Catalio +6
664x BioSeries A · $55M · leadSV Angel, Refactor, Future Ventures +6

How Lifeforce Capital invests

StageDealsCapital in rounds
Series A 2 50%$73M
Series B+ 2 50%$262.5M
YearDealsCapital in rounds
2022 3 75%$220.5M
2025 1 25%$115M

Lifeforce Capital portfolio companies

CompanyRound with Lifeforce CapitalTotal raisedLatest raise
AAspen Neuroscience
Health and bio
Series B+ · $115M$339MNov 20, 2025
Series B+
CCharacter Bio
Health and bio
Series A · $18M$111MMar 25, 2025
Series B+
664x Bio
Health and bio
Series A · $55M · lead$55MJan 19, 2022
Series A
EEnveda
Health and bio
backer$714MSep 23, 2026
Series B+
FFauna Bio
Health and bio
backer$9MMar 14, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 4 rounds on Recent Funding that name Lifeforce Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Lifeforce Capital, which is a subset of its real portfolio. API: /api/v1/investors/lifeforce-capital (get a free API key). More: the most active VC firms and new venture capital funds.